Cite
Rockstroch JK, Soriano V, Plonski F, et al. Corrigendum. Hepatic Safety in Subjects With HIV-1 and Hepatitis C and/or B Virus: A Randomised, Double-Blind Study of Maraviroc vs Placebo in Combination With Antiretroviral Agents. HIV Clin Trials. 2015;16(6):236-7doi: 10.1080/15284336.2015.1124625.
Rockstroch, J. K., Soriano, V., Plonski, F., Bansal, M., Fätkenheuer, G., Small, C. B., Asmuth, D. M., Pialoux, G., Mukwaya, G., Jagannatha, S., Heera, J., & Pineda, J. A. (2015). Corrigendum. Hepatic Safety in Subjects With HIV-1 and Hepatitis C and/or B Virus: A Randomised, Double-Blind Study of Maraviroc vs Placebo in Combination With Antiretroviral Agents. HIV clinical trials, 16(6), 236-7. https://doi.org/10.1080/15284336.2015.1124625
Rockstroch, Jùrgen K, et al. "Corrigendum. Hepatic Safety in Subjects With HIV-1 and Hepatitis C and/or B Virus: A Randomised, Double-Blind Study of Maraviroc vs Placebo in Combination With Antiretroviral Agents." HIV clinical trials vol. 16,6 (2015): 236-7. doi: https://doi.org/10.1080/15284336.2015.1124625
Rockstroch JK, Soriano V, Plonski F, Bansal M, Fätkenheuer G, Small CB, Asmuth DM, Pialoux G, Mukwaya G, Jagannatha S, Heera J, Pineda JA. Corrigendum. Hepatic Safety in Subjects With HIV-1 and Hepatitis C and/or B Virus: A Randomised, Double-Blind Study of Maraviroc vs Placebo in Combination With Antiretroviral Agents. HIV Clin Trials. 2015 Nov;16(6):236-7. doi: 10.1080/15284336.2015.1124625. PMID: 26777796.
Copy
Download .nbib
